Bifidobacterium longum subsp. infantis M-63
Bifidobacterium longum subsp. infantis (B. infantis) is associated with improved growth, the development of intestinal membrane integrity, and is critical for developing immune function.*
The Developing Intestinal Microflora of Newborns Is Up to 90% B. Infantis
B. infantis is the predominant intestinal organism found in breast-fed infants.* B. infantis M-63 was isolated from a healthy infant and clinically proven to colonize the intestines of infants.*
B. infantis is the only bacterial species able to take up and metabolize all Human Milk Oligosaccharides (HMOs) which allows B. infantis to outcompete other bacterial species.*
Jarro-Dophilus® Infant is formulated with Medium Chain Triglycerides (MCTs), which are naturally present in breast milk and are more easily absorbed by the newborn’s immature digestive system.*
1 Billion CFU / 2.04 fl. oz. (15 ml) Liquid / 4 Months Supply
|Serving Size 10 Drops (0.5 ml)|
|Servings Per Container About 30|
|Amount Per Serving|
|Bifidobacterium longum subsp. infantis M-63||12.5 mg (1 Billion CFU) †|
|† Daily Value (DV) not established.|
About Jarro-Dophilus® Infant
Did you know?
Our scientists leverage expertise from renowned researchers in institutions worldwide who study ingredients and products and how they work with your body. Jarrow Formulas maintains superior science as the guiding principle in all it does.
Our formulations are carefully crafted to ensure you get the biological value of each and every vitamin, mineral and supplement. Informed by strong scientific research, Jarrow Formulas’ products therefore have the potential to support and promote optimal health.
Our customers can be assured of both purity and potency in every Jarrow Formulas product. We evaluate the purity, strength and composition of all ingredients and only work with raw material suppliers that follow the same Current Good Manufacturing Practices (cGMP) we do.